Apolipoprotein E (APOE) Polymorphisms and Susceptibility to Breast Cancer: A Meta-Analysis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Apolipoprotein E (APOE, MIM: 107741) has three functionally distinct isoforms of the protein (E2,E3, and E4), encoded by corresponding alleles ε2, ε3, and ε4, which have been well described. Findings from previous studies investigating association between APOE polymorphisms and breast cancer risk have been inconsistent. The present meta-analysis was conducted in order to investigate association of APOE polymorphisms with risk of breast cancer. Materials and Methods Several electronic databases were used for identification of studies containing information on APOE polymorphisms and breast cancer risk published up to January 2012. We identified 10eligible studies, including 3,835 subjects (2008 patients, and 1,827 healthy controls), that reported on polymorphisms of APOE and risk of breast cancer. Summary odds ratios (ORs) and 95%confidence intervals (CIs) were obtained using a fixed and random-effects models. Results Among studies reported from Asia, an association of the ε4 allele with increased risk of breast cancer, in comparison with the ε3 allele, was observed (OR, 1.56; 95% CI, 1.19 to 2.04; p=0.001). It should be noted that allele ε2 showed no association with breast cancer risk. Among Caucasians,neither the ε4 (OR, 0.99; 95% CI, 0.83 to 1.17; p=0.917) nor the ε2 (OR, 0.92; 95% CI, 0.72 to 1.17;p=0.514) allele showed an association with susceptibility to breast cancer, when compared with the ε3 allele. Carriers of the ε4 allele (E4E4, E4E3, and E4E2 genotypes), in comparison with the E3E3 genotype, showed an association with elevated risk of breast cancer only among Asians (OR, 1.75; 95% CI, 1.23 to 2.47; p=0.002). No publication bias was detected. Conclusion This meta-analysis suggest that the APOEε4 allele is a low-penetrant risk factor for development of breast cancer.
Abstract
Purpose Apolipoprotein E (APOE, MIM: 107741) has three functionally distinct isoforms of the protein (E2,E3, and E4), encoded by corresponding alleles ε2, ε3, and ε4, which have been well described. Findings from previous studies investigating association between APOE polymorphisms and breast cancer risk have been inconsistent. The present meta-analysis was conducted in order to investigate association of APOE polymorphisms with risk of breast cancer. Materials and Methods Several electronic databases were used for identification of studies containing information on APOE polymorphisms and breast cancer risk published up to January 2012. We identified 10eligible studies, including 3,835 subjects (2008 patients, and 1,827 healthy controls), that reported on polymorphisms of APOE and risk of breast cancer. Summary odds ratios (ORs) and 95%confidence intervals (CIs) were obtained using a fixed and random-effects models. Results Among studies reported from Asia, an association of the ε4 allele with increased risk of breast cancer, in comparison with the ε3 allele, was observed (OR, 1.56; 95% CI, 1.19 to 2.04; p=0.001). It should be noted that allele ε2 showed no association with breast cancer risk. Among Caucasians,neither the ε4 (OR, 0.99; 95% CI, 0.83 to 1.17; p=0.917) nor the ε2 (OR, 0.92; 95% CI, 0.72 to 1.17;p=0.514) allele showed an association with susceptibility to breast cancer, when compared with the ε3 allele. Carriers of the ε4 allele (E4E4, E4E3, and E4E2 genotypes), in comparison with the E3E3 genotype, showed an association with elevated risk of breast cancer only among Asians (OR, 1.75; 95% CI, 1.23 to 2.47; p=0.002). No publication bias was detected. Conclusion This meta-analysis suggest that the APOEε4 allele is a low-penetrant risk factor for development of breast cancer.
참고문헌 (25)
- Weisgraber KH, "Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms", J Biol Chem, 256, pp.9077~9083 (1981)
- Rall SC Jr, "Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects", Proc Natl Acad Sci U S A, 79, pp.4696~4700 (1982)
- Moysich KB, "Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk", Mol Carcinog, 27, pp.2~9 (2000)
- Niemi M, "Apolipoprotein E phenotype, cholesterol and breast and prostate cancer", J Epidemiol Community Health, 54, pp.938~939 (2000)
- Yaylim I, "The apolipoprotein E epsilon 4 allele is not a risk factor for Turkish breast cancer patients", Cancer Genet Cytogenet, 146, pp.86~87 (2003)
- Menzel HJ, "Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations", Br J Cancer, 90, pp.1989~1994 (2004)
- Chang NW, "Influences of apolipoprotein E polymorphism on the risk for breast cancer and HER2", neu status in Taiwan, 2005, pp.90, 257~261
- Chang SJ, "Association between the apolipoprotein E genotypes and breast cancer patients in Taiwanese", Breast Cancer Res Treat, 98, pp.109~113 (2006)
- Surekha D, "Influence of apolipoprotein e gene polymorphism on the risk for breast cancer", Int J Hum Genet, 8, pp.277~282 (2008)
- Porrata-Doria T, "Apolipoprotein E allelic frequency altered in women with early-onset breast cancer", Breast Cancer(Auckl), 4, pp.43~48 (2010)
- Mantel N, "Statistical aspects of the analysis of data from retrospective studies of disease", J Natl Cancer Inst, 22, pp.719~748 (1959)
- DerSimonian R, "Meta-analysis in clinical trials", Control Clin Trials, 7, pp.177~188 (1986)
- Egger M, "Bias in meta-analysis detected by a simple, graphical test", BMJ, 315, pp.629~634 (1997)
- Niu W, "The relationship between apolipoprotein E epsilon2", epsilon3, Hypertens Res, pp.2009, 32[DOI]
- Bennet AM, "Association of apolipoprotein E genotypes with lipid levels and coronary risk", JAMA, 298, pp.1300~1311 (2007)
- Carroll KK, "Fat and cancer", Cancer, 58(8 Suppl), pp.1818~1825 (1986)
- Agurs-Collins T, "Plasma lipid alterations in African-American women with breast cancer", J Cancer Res Clin Oncol, 124, pp.186~190 (1998)
- Takatani O, "Genesis of breast cancer in Japanese: a possible relationship between sex hormone binding globulin (SHBG) and serum lipid components", Breast Cancer Res Treat, 18(Suppl 1), pp.S27~S29 (1991)
- Tanne JH, "Apo E4 gene linked to breast cancer", BMJ, 319, pp.662~ (1999)
- Kiyohara C, "Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk : a meta-analysis", Lung Cancer, 54, pp.267~283 (2006)
- Saadat M, "Genetic polymorphisms of glutathione S-transferase T1(GSTT1)and susceptibility to gastric cancer : a meta-analysis", Cancer Sci, 97, pp.505~509 (2006)
- Saadat M, "Genetic polymorphism of glutathione S-transferase T1, M1 and asthma, a meta-analysis of the literature", Pak J Biol Sci, 10, pp.4183~4189 (2007)
- Saadat M, "Polymorphism of XRCC1(at codon 399)and susceptibility to breast cancer, a meta-analysis of the literatures", Breast Cancer Res Treat, 115, pp.137~144 (2009)
- Qiu LX, "XPD Lys751Gln polymorphism and breast cancer susceptibility : a meta-analysis involving 28, 709 subjects", Breast Cancer Res Treat, 124, pp.229~235 (2010)
- Yao L, "The association between ERCC2 Asp312Asn polymorphism and breast cancer risk : a meta-analysis involving 22, 766 subjects", Breast Cancer Res Treat, 123, pp.227~231 (2010)